VEGF and mTOR converge at HIF and VEGFR inhibitors are more effective in clear cell RCC (75%–80% of RCC are clear cell23) where Von Hippel Lindau (VHL) genes are mutated or deleted.25 The gene discussed is MTOR; the disease is renal cell adenocarcinoma.